Angiotensin Receptor Blockers for the Prevention of Atrial Fibrillation Recurrences: Unending Hot Debate
- PMID: 28496673
- PMCID: PMC4955907
- DOI: 10.4022/jafib.306
Angiotensin Receptor Blockers for the Prevention of Atrial Fibrillation Recurrences: Unending Hot Debate
References
-
- Ehrlich Joachim R, Hohnloser Stefan H, Nattel Stanley. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur. Heart J. 2006 Mar;27 (5):512–8. - PubMed
-
- Healey Jeff S, Baranchuk Adrian, Crystal Eugene, Morillo Carlos A, Garfinkle Michael, Yusuf Salim, Connolly Stuart J. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J. Am. Coll. Cardiol. 2005 Jun 07;45 (11):1832–9. - PubMed
-
- Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000 Jun 06;101 (22):2612–7. - PubMed
-
- Goette A, Arndt M, Röcken C, Spiess A, Staack T, Geller J C, Huth C, Ansorge S, Klein H U, Lendeckel U. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000 Jun 13;101 (23):2678–81. - PubMed
-
- Disertori Marcello, Latini Roberto, Barlera Simona, Franzosi Maria Grazia, Staszewsky Lidia, Maggioni Aldo Pietro, Lucci Donata, Di Pasquale Giuseppe, Tognoni Gianni. Valsartan for prevention of recurrent atrial fibrillation. N. Engl. J. Med. 2009 Apr 16;360 (16):1606–17. - PubMed
Publication types
LinkOut - more resources
Full Text Sources